Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence (2020)
- Authors:
- Autor USP: SOARES, IRENE DA SILVA - FCF
- Unidade: FCF
- DOI: 10.1128/AAC.02056-19
- Subjects: PLASMODIUM; MALÁRIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2020
- Source:
- Título do periódico: Antimicrobial Agents and Chemotherapy
- ISSN: 1098-6596
- Volume/Número/Paginação/Ano: v. 64, n. 5, p. 1-14 art. e02056-19, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
SILVINO, Ana Carolina Rios et al. Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence. Antimicrobial Agents and Chemotherapy, v. 64, n. 5, p. 1-14 art. e02056-19, 2020Tradução . . Disponível em: https://doi.org/10.1128/AAC.02056-19. Acesso em: 11 jun. 2024. -
APA
Silvino, A. C. R., Kano, F. S., Costa, M. A., Fontes, C. J. F., Soares, I. da S., Brito, C. F. A. de, et al. (2020). Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence. Antimicrobial Agents and Chemotherapy, 64( 5), 1-14 art. e02056-19. doi:10.1128/AAC.02056-19 -
NLM
Silvino ACR, Kano FS, Costa MA, Fontes CJF, Soares I da S, Brito CFA de, Carvalho LH, Sousa TN de. Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 5): 1-14 art. e02056-19.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1128/AAC.02056-19 -
Vancouver
Silvino ACR, Kano FS, Costa MA, Fontes CJF, Soares I da S, Brito CFA de, Carvalho LH, Sousa TN de. Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 5): 1-14 art. e02056-19.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1128/AAC.02056-19 - Antibody response after vaccination of mice with two new Plasmodium vivax circumsporozoite proteins fused to Mumps virus nucleocapsid
- Immunogenicity of the Plasmodium vivax apical membrane antigen 1 (PvAMA-1): Comparison of homologous and heterologous prime-boost strategies using naked DNA and recombinant protein produced in Pichia pastoris
- Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates ('PvMSP-1 IND. 19') and 'PvMSP-3α IND. 359-798' and their relationship with hematological features in malaria patients from the Brazilian Amazon
- Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1
- Antibody response to the C-terminal region of the Plasmodium vivax merozoite surface protein 1 in individuals living in an area of stable and exclusive transmission of P. vivax malaria
- Immunogenicity comparison of two recombinant proteins based on circumsporozoite (CSP) of Plasmodium vivax
- Evaluation of cytokines expression by T lymphocytes from mice immunized with Plasmodium vivax circumsporozoite protein in the presence of Poly IC or Montanide ISA 720
- Antibody response to a new member of the DBL family (EBP2) after a brief Plasmodium vivax exposure
- IgM antibody responses against Plasmodium antigens in neotropical primates in the Brazilian Atlantic Forest
- The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate
Informações sobre o DOI: 10.1128/AAC.02056-19 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas